Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
FDA lists BPC-157 among 503A Category-2 ingredients that present significant safety risks for traditional compounding
Generally yes, but several herbs in this protocol have known interactions with anticoagulants, NSAIDs, and drugs absorbed through the gut
Cardiovascular and neuroprotective benefits become more pronounced
A 2020 review on the safety of BPC-157 in preclinical (animal) studies states that the peptide did not show any test-related effects in the single-dose toxicity study and that it was well tolerated in repeat-dose evaluations.16 Other animal studies and reviews mention that BPC-157 has no reported toxicity or that it was without a lethal dose in toxicology studies.14 17 Even the authors of a small human study on BPC-157 for interstitial cystitis note that no one dropped out of the study, and no adverse events were reported.18 We want to highlight that most of the relevant studies have been conducted on animals, and more human research is needed
US$ 28.03
US$ 20.11
US$ 20.20
US$ 22.12
US$ 29.09
